BiotechTubeBiotechTube
TuHURA Biosciences

TuHURA Biosciences

Phase 3
Tampa, United StatesFounded 2019tuhurabio.com

Develops cancer immunotherapies using myeloid cell reprogramming and bispecific antibody platforms.

Founded
2019
Focus
RNA & Gene Therapy

About

Develops cancer immunotherapies using myeloid cell reprogramming and bispecific antibody platforms.

Funding History

2

Total raised: $90M

Series B$65MBristol Myers SquibbFeb 15, 2023
Series A$25MMorningside VenturesJun 15, 2021

Company Info

TypePrivate
Founded2019
LocationTampa, United States
StagePhase 3

Contact

tuhurabio.com

Sectors

RNA Therapeutics (non-mRNA)Cell & Gene Therapy
SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile